TSX:CURAPharmaceuticals
Curaleaf Holdings (TSX:CURA) Valuation Check As FDA Eases Stance On Certain CBD Regulations
The latest move in Curaleaf Holdings (TSX:CURA) comes as the FDA signals it will not enforce certain regulations on CBD products, a regulatory shift that has lifted sentiment across cannabis stocks.
See our latest analysis for Curaleaf Holdings.
The 8.04% 1 day share price return to CA$3.36 has come on top of several recent updates, including new dispensaries in Florida and Ohio and the launch of Select Briq 2. However, the 90 day share price return of 6.15% and 5 year total shareholder...